医学
Paper Review Records
全部论文审稿周期
5 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
ASH clinical practice guidelines: evaluation of discordance between certainty of evidence and strength of recommendations
作者Samantha A. Hershenfeld; Robert Kunkle; Menaka Pai; Adam Cuker; Matthew C. Cheung
作者单位1. 1Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada; 2. 2American Society of Hematology, Washington, DC; 3. 3Department of Medicine, McMaster University, Hamilton, Canada; 4. 4Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; 5. 5Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Bispecific antibody therapy in multiple myeloma and risk of progressive multifocal leukoencephalopathy
作者Jean-Roch Le Henaff; Loïc Le Guennec; Pauline Schiro; Kevin Bihan; Jacques Gasnault; Bruno Stankoff; Yassine Taoufik; Emmanuel Treiner; Danièle Bensoussan; Sébastien Lhomme; Anne-Sophie L’Honneur; Fabrice Bonneville; Natalia Shor; Valérie Pourcher; Béatrice Pignolet; Baptiste Lievin; Clément Javaux; Julien Le Guen; Eolia Brissot; Pierre-Antoine Limouzin; Clémence Richaud; Bruno Lioure; Thomas Wirth; Paul Petitgas; Simon Herbel; François Coustillères; Elena-Camelia Rusu; Laura Maerten; Aurore Perrot; Agnès Sommet; Damien Roos-Weil; Margaux Lafaurie; Nicolas Weiss; Guillaume Martin-Blondel; P. Rispal; R. Dhersin; V. Dubée; J. Paillassa; A.S. Valadoux; E. Piet; S. Arista; S. Ancellin; O. Paccoud; A. Serris; F. Lanternier; C. Duvivier; C. Vignals; F. Lantier; V. Delcey; A. Moussiegt; M. El Soudany; D. Brebant; I. Charachon; M. Gilbert; X. Lescure; S. Lariven; B. Denis; E. Rubenstein; C. Barsan; R. Ursu Billot; N. Crainic; F. Mechai; S. Abad; R. Courtois; A. Durrbach; C. Cauquil; Y. Quertainmont; J. Pacanowski; A. Capes; A. Banet; Q. Richier; O. Heinzlef; A. De la Selle; A.L. Houist; G. Melica; W. Vindrios; V. Esnault; M. Mahevas; G. Volle; E. Mortier; F. Finet; N. Mele; A. Chabrol; M.E. Vekemans; C. De la Porte; C. Batot; E. Chaugne; Y. Beigneux; J. Garcia; M. Dorel; J. Sarrabere; C. Tivenez; H. Chaussade; M. Mehlen; C. Cazanave; F. Dauchy; C. Vignals; E. Forcade; C. Bellissard; W. Meissner; L. Hobeika; M. Pinel; T. Sooltangos; K. Abdelmoumen; F. Bourdain; P. Da Silva; P. Gazeau; R. Paret; D. Marechal; F.M. Merrien; E. Legras; M. Tore; C. Theis; O. Tournilhac; M. Raquin; A. Zaghdoudi; S. Abidh; S. Sire; H. Frahier; G. Ahle; F. Medina; M. Blot; V. Viziolo; I. Aouissi; L. Elmansouf; G. Gaube; A. Leurs; C. Lesoil-Markowski; J. Poupart; E. Laborde; O. Epaulard; M. Le Maréchal; G. Wuillaume; O. Casez; C. Lahuna; S. Markowicz; K. Schepers; S. Devatine; T. Dequidt; T. Coman; F. Andry; A. Thomas; E. Durand; C. Badr; T. Chedid; H. Ferrand; P. Chauvet; J. Lannoy; D. Beauvais; P. Martin-Pawlowski; C. Desprez; P. Kerschen; F. Gobert; B. Andorra; M. Dion; T. Perpoint; Y. Malek; F. Hubben; P. Dumez; B. Bouchacourt; Z. Poullet; V. Eiferman; A. Crepet; N. Cassir; M. Villessot; A. Tershiphorst; P. Prin; A. Formoso; L. Corti; E. Thomas; A. Simon; L. Taillandier; C. Biron; A. Seguin; C. Antier; B. Piron; M. Prime; C. Delaunay; M. Levraut; L. Inchiappa; P. Pereyra; Corazza; O. Thomel-Rocchi; M. Chiaruzzi; F. Villa; C. Tafani; L. Mokri; O. Lacatus; P. Tattevin; M. Revest; T. Nivet; F. Benezit; L. Armange; M. Leclercq; L. Picard; E. Le Tallec; B. Cador; S. Ardois; S. Belliard; A. Bachelot; M. El Acheck; M. Marc; J. Calmettes; C. Henry; E. Pappa; V. Hean; J.P. Camdessanche; A. Zilliox; Y. Boudard; S. Cunat; P. Perrin; B. Hoellinger; N. Douiri; N. Benmoussa; F. El-Bahri; S. Viguier; C. Rual; N. Vidal; P. Delobel; X. Boumaza; L. Mazet; S. Lagarrigue; A. Frelat; G. Gombert; J. Ciron; D. Biotti; M. Rafiq; M. Roussel; J. Pariente; B. Gachet; M Tetard; A. Meybeck; B. Cappeliez; G. Perrin; Y. Conan; O. Motica; M. Lacasse; L. Letranchant; Y. Bleher; D. Merrien; G. Vergne; N. Testard; R. Collot
作者单位1. 1Department of Infectious and Tropical Diseases, Toulouse University Hospital, Toulouse, France; 2. 2Neo-I3D Research Group, Toulouse University Hospital, Toulouse, France; 3. 3Department of Medical and Clinical Pharmacology, Centre of Pharmacovigilance and Pharmacoepidemiology, Clinical Investigation Center 1436, Faculty of Medicine, Toulouse University Hospital, Toulouse, France; 4. 4Service de Médecine Intensive Réanimation à orientation neurologique, Sorbonne Université, Hôpital de la Pitié Salpêtrière, Assistance Publique–Hôpitaux de Paris, Paris, France; 5. 5OncoNeuroTox ICU Study Group, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France; 6. 6Department of Pharmacology, Clinical Investigation Center 1901, Regional Pharmacovigilance Centre, Pitié-Salpêtrière Hospital, Assistance Publique–Hôpitaux de Paris, Paris, France; 7. 7Unit of Neuroinfectious Rehabilitation, Department of Internal Medicine and Clinical Immunology, Bicêtre University Hospital, Le Kremlin-Bicêtre, Assistance Publique–Hôpitaux de Paris, Paris, France; 8. 8INSERM U1356, Gustave Roussy Institute, Villejuif, France; 9. 9Neurology Department, Sorbonne University, Paris Brain Institute, INSERM, CNRS, Pitié Salpetriere Hospital, APHP, Paris, France; 10. 10Department of Hematology and Immunology, Bicêtre Hospital, Paris-Saclay University, Assistance Publique–Hôpitaux de Paris, Le Kremlin-Bicêtre, France; 11. 11Department of Immunology, Toulouse University Hospital, Toulouse, France; 12. 12Toulouse Institute for Infectious and Inflammatory Diseases, INSERM UMR1291, CNRS UMR5051, Toulouse University, Toulouse, France; 13. 13Cell Therapy Unit, Nancy University Hospital, Vandoeuvre-lès-Nancy, France; 14. 14Department of Virology, Toulouse University Hospital, Toulouse, France; 15. 15Department of Virology, Paris Cité University, Cochin Hospital, Paris, France; 16. 16Department of Neuroradiology, Toulouse University Hospital, Toulouse, France; 17. 17Department of Neuroradiology, Pitié-Salpêtrière Hospital, Assistance Publique–Hôpitaux de Paris, Sorbonne Université, Paris, France; 18. 18Department of Infectious Diseases, Sorbonne University, Assistance Publique–Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, Paris, France; 19. 19INSERM UMR-1136, Institut Pierre Louis d’Epidémiologie et de Santé Publique, Paris, France; 20. 20Department of Infectious and Tropical Diseases, Croix Rousse University Hospital, Hospices Civils de Lyon, Lyon, France; 21. 21Service de Gériatrie, Hôpital Européen Georges Pompidou, Assistance Publique–Hôpitaux de Paris, Paris, France; 22. 22Service d’Hématologie Clinique et Thérapie Cellulaire, Centre de Recherche de Saint-Antoine, Sorbonne University, Hôpital Saint-Antoine, Assistance Publique–Hôpitaux de Paris, INSERM, UMRs938, Paris, France; 23. 23Department of Neurology, CHU Pellegrin, Bordeaux, France; 24. 24Department of Infectious and Tropical Diseases, CHU Gabriel Montpied, Clermont-Ferrand, France; 25. 25Unité de Greffe de Cellules Souches Hématopoïétiques, Hôpitaux Universitaires de Strasbourg, Strasbourg, France; 26. 26Department of Neurology, University Hospital of Strasbourg, Strasbourg, France; 27. 27Strasbourg Neuroscience Institute, Strasbourg University, Strasbourg, France; 28. 28Institute of Genetics and Cellular and Molecular Biology, INSERM-U964, CNRS-UMR7104, University of Strasbourg, Illkirch-Graffenstaden, France; 29. 29Department of Infectious and Tropical Diseases, Quimper Hospital, Quimper, France; 30. 30Service de Maladies Infectieuses et Tropicales, Hôpital Necker-Enfants Malades, Université Paris Cité, Assistance Publique–Hôpitaux de Paris, Paris, France; 31. 31Department of Infectious Diseases, Tours University Hospital, Tours, France; 32. 32Department of Neurology, Toulon Hospital, Toulon, France; 33. 33Department of Internal Medicine, Hôpital Avicenne, Assistance Publique–Hôpitaux de Paris, Paris, France; 34. 34Department of Hematology, Toulouse University Hospital, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse University, Toulouse, France; 35. 35Hematology Unit, CHU Pitié-Salpêtrière, Sorbonne Université, Paris, France; 36. 36Médecine Intensive Réanimation, Hôpital de la Pitié-Salpêtrière, Sorbonne Université, Assistance Publique–Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris, France
In vivo evidence of effective complement modulation by TriFu in comparison to C5 inhibition and complement depletion
作者Susa Savukoski; Alina Maria Dettner; Anke Schultze; Christoph Gerber; Michael Stefan Steinberger; Rebecca Halbgebauer; Peter Melter; Arthur Dopler; Annette Palmer; Christian Karl Braun; Susanne Hafner; Bo Nilsson; Kristina Nilsson-Ekdahl; Tom Eirik Mollnes; Raban Heller; Hubert Schrezenmeier; Christoph Q. Schmidt; Markus S. Huber-Lang; Marco Mannes
作者单位1. 1Institute of Clinical and Experimental Trauma Immunology, Ulm University Medical Center, Ulm, Germany; 2. 2Institute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm University Medical Center, Ulm, Germany; 3. 3Department for Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany; 4. 4German Center for Child and Adolescent Health, Partner Site Ulm, Ulm, Germany; 5. 5Department of Immunology, Genetics and Pathology, Rudbeck Laboratory C5:3, Uppsala, Sweden; 6. 6Linnaeus Centre of Biomaterials Chemistry, Linnaeus University, Kalmar, Sweden; 7. 7Department of Immunology, Oslo University Hospital, University of Oslo, Oslo, Norway; 8. 8Research Laboratory, Nordland Hospital, Bodo, Norway; 9. 9Department for Trauma Surgery, Orthopaedics, Reconstructive and Septic Surgery, and Sports Traumatology, German Armed Forces Hospital Ulm, Ulm, Germany; 10. 10Institute of Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service Baden-Wuerttemberg-Hessen and University Hospital Ulm, Ulm, Germany; 11. 11Institute of Transfusion Medicine, University Hospital Ulm, Ulm, Germany
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。